This brief provides background on gender affirming care and state bans, explains the legal challenge to the Tennessee law, and explores the potential Supreme Court ruling and impact on access across the country.
This brief provides background on gender affirming care and state bans, explains the legal challenge to the Tennessee law, and explores the potential Supreme Court ruling and impact on access across the country.
Roche is acquiring Poseida Therapeutics, a biotech developing allogeneic cell therapies for...
ByglobalreutersNovember 26, 2024By KIM BELLARD A year ago I wrote about disturbing news from...
ByglobalreutersNovember 26, 2024BridgeBio Pharma claims its drug, Attruby, has an edge over a Pfizer...
ByglobalreutersNovember 25, 2024The Pink Sheet reports on a new international health technology assessment (HTA)...
ByglobalreutersNovember 25, 2024
Leave a comment